Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Moderna, Inc. (MRNA) vs Virgin Galactic Holdings, Inc. (SPCE) Price & Performance

Moderna, Inc.Trade
Virgin Galactic Holdings, Inc.Trade

Price performance (Past 24H)

Key statistics

Moderna, Inc. vs Virgin Galactic Holdings, Inc. — how do they compare? Moderna, Inc. trades at $60.83 (market cap $23.88B), while Virgin Galactic Holdings, Inc. trades at $3.29 (market cap $488.94M). The key difference: Moderna, Inc. is far larger — about 48.8× Virgin Galactic Holdings, Inc.'s market cap, and Moderna, Inc. is trading nearer its 52-week high, Virgin Galactic Holdings, Inc. nearer its low. Which is the better fit depends on your goals.

MRNASPCE
Market Cap
$23.88B$488.94M
Sector
HealthIndustrials
52-Week High
$81.80$7.52
52-Week Low
$22.36$2.17
Enterprise Value
$20.03B$588.79M

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

Read more on MRNA

About Virgin Galactic Holdings, Inc.

Virgin Galactic Holdings Inc. develops space vehicles. The Company designs exploration technology such as missiles, rockets, and other related equipment. Virgin Galactic Holdings serves customers in the United States.

Read more on SPCE